PUBLICAÇÕES científicas

Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK

Pennington B (1), Akehurst R (2), Wasan H (3), Sangro B (4), Kennedy AS (5), Sennfält K (6), Bester L (7).
(1a) BresMed , Sheffield , UK.
(2b) University of Sheffield , Sheffield , UK.
(3c) Medical Oncology, Hammersmith Hospital, Imperial NHS Trust , London , UK.
(4d) Liver Unit, Clinica Universidad de Navarra, Pamplona, Spain; and Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD) , Pamplona , Spain.
(5e) Radiation Oncology, Sarah Cannon Research Institute , Nashville , TN , USA.
(6f) Sirtex Medical Limited , North Sydney , NSW , Australia.
(7g) Interventional Radiology, University of New South Wales, St. Vincent's Hospital , Darlinghurst , NSW , Australia. 

Revisão:Journal of Medical Economics

Data: 9/Jun/2015

Hepatologia

OBJECTIVE:
Selective internal radiation therapy (SIRT) using SIR-Spheres(®) (90)Y-labeled resin microspheres has been shown to be a well-tolerated, effective treatment in patients with inoperable liver-dominant chemotherapy-refractory metastatic colorectal cancer (mCRC). This study estimated the cost-effectiveness of (90)Y-resin microspheres compared to best supportive care (BSC) from a UK perspective.

METHODS:
Survival data from a comparative retrospective cohort study was analyzed and used in a state-transition cost-effectiveness model, using quality-adjusted life years (QALYs) gained as the measure of effectiveness. The model incorporated costs for the SIRT procedure, monitoring, further treatment, adverse events, and death. Utility values, reflecting patient quality-of-life, were taken from a published source.

RESULTS:
SIRT using (90)Y-resin microspheres compared to BSC improved overall survival by a mean of 1.12 life years and resulted in a cost per QALY gained of £28,216. In sensitivity analysis, this varied between £25,015-£28,817.

CONCLUSION:
In an area of large unmet need, treatment with (90)Y-resin microspheres offers a clinically effective and cost-effective treatment option.

CITAÇÃO DO ARTIGO  J Med Econ. 2015;18(10):797-804. doi: 10.3111/13696998.2015.1047779. Epub 2015 Jun 9.

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra